Pharmabiz1h
Context Therapeutics receives US FDA clearance of IND application for phase 1 clinical trial of CTIM-76
Context Therapeutics receives US FDA clearance of IND application for phase 1 clinical trial of CTIM-76: Philadelphia Saturday, May 4, 2024, 18:00 Hrs [IST] Philadelphia-headquart ...
Pharmabiz2h
Pluri launches immunotherapy platform for solid tumour cancer treatment
Pluri launches immunotherapy platform for solid tumour cancer treatment: Haifa, Israel Saturday, May 4, 2024, 17:00 Hrs [IST] Pluri Inc, a leading biotechnology company that trans ...
Pharmabiz3h
US FDA clarifies approach to genomic alterations in animals
The US Food and Drug Administration (FDA) took important steps to advance the FDA’s regulatory process for intentional genomic alterations (IGAs) in animals. The updated guidance documents underscore ...
Pharmabiz4h
Epredia, NovaScan to ink distribution agreement for MarginScan to aid doctors to detect non-melanoma skin cancer
Portsmouth, New Hampshire Saturday, May 4, 2024, 15:00 Hrs [IST] ...
Pharmabiz5h
UK MHRA grants marketing approval for ViiV Healthcare’s cabotegravir formulations to help prevent HIV-1 infection in adults and adolescents
UK MHRA grants marketing approval for ViiV Healthcare’s cabotegravir formulations to help prevent HIV-1 infection in adults and adolescents: United Kingdom Saturday, May 4, 2024 ...
Pharmabiz5h
PharmaTech Expo serves as catalyst for driving innovation
The 16th Edition of PharmaTech Expo 2024 & LabTech Expo 2024 held from April 12 to 14, 2024 at Parade Ground, Chandigarh, organized by PharmaTechnologyIndex.com Pvt. Ltd, served as a catalyst for ...
Pharmabiz6h
Walgreens, Boehringer Ingelheim collaborate to improve diversity in clinical trials
Walgreens, Boehringer Ingelheim collaborate to improve diversity in clinical trials: Deerfield, Illinois Saturday, May 4, 2024, 13:00 Hrs [IST] Walgreens, an integrated healthcare ...
Pharmabiz7h
Angle signs commercial agreement with Large Pharma to develop Parsortix-based androgen receptor
Angle signs commercial agreement with Large Pharma to develop Parsortix-based androgen receptor: Gildford, England Saturday, May 4, 2024, 12:00 Hrs [IST] Angle plc, a world-leadin ...
Pharmabiz8h
IDIA and WHO renew collaboration on scale-up of health innovations
IDIA and WHO renew collaboration on scale-up of health innovations: Geneva Saturday, May 4, 2024, 11:00 Hrs [IST] The World Health Organization (WHO) and the International Develop ...
Pharmabiz10h
Telangana DCA conducts raid in quack’s clinics and seize drugs worth Rs. 1.60 lakh
Telangana DCA conducts raid in quack’s clinics and seize drugs worth Rs. 1.60 lakh: Our Bureau, Chennai Saturday, May 4, 2024, 09:00 Hrs [IST] After two days raids in a quack’ ...
Pharmabiz11h
Pharmac South 2024 to organize special conference on Revised Schedule M on May 24
Pharmac South 2024 to organize special conference on Revised Schedule M on May 24: Peethaambaran Kunnathoor, Chennai Saturday, May 4, 2024, 08:00 Hrs [IST] Alongside the 9th South ...
Pharmabiz11h
Pharmexcil DG asks member cos to participate in BTM 2024 to foray into Costa Rican pharma market
Pharmexcil DG asks member cos to participate in BTM 2024 to foray into Costa Rican pharma market: Shardul Nautiyal, Mumbai Saturday, May 4, 2024, 08:00 Hrs [IST] In anticipation o ...